TECH

$TECH

Bio-Techne Corporation

Life sciences company providing proteins, antibodies, and diagnostics for research.

Healthcare
$72.70
-0.05 (-0.07%)
Day Range$72.69 - $72.76
Prev Close$72.75

TECH key facts as of November 14, 2026

Latest AI research report
TECH Stock Analysis: Growth, Valuation and Risks (as of November 14, 2026)
StockAlpha report sentiment
Neutral (as of November 14, 2026)
Analyst consensus
Hold (0 Strong Buy, 0 Buy, 12 Hold, 1 Sell, 0 Strong Sell) (as of November 1, 2026)
Analyst price target
$71.67 mean (range $65.00 to $73.00) (as of November 20, 2026)
Sector
Healthcare
Analyst Rating
Hold
0 Buy / 12 Hold / 1 Sell
Price Target
$71.67
-1.4% downside
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Nov 14, 2026

NEUTRAL

TECH Stock Analysis: Growth, Valuation and Risks

Bio-Techne’s shares closed near their 52-week high as analysts weighed recent operating results and progress on a Merck KGaA merger deal. Growth and liquidity are positive, but earnings trends, premium valuation, and price targets below the close leave the outlook mixed.

Nov 14, 2026

TECH FAQ

What is StockAlpha's latest view on TECH?

StockAlpha's latest AI research report on Bio-Techne Corporation (TECH), "TECH Stock Analysis: Growth, Valuation and Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. Bio-Techne’s shares closed near their 52-week high as analysts weighed recent operating results and progress on a Merck KGaA merger deal. Growth and liquidity are positive, but earnings trends, premium valuation, and price targets below the close leave the outlook mixed.

When was the TECH research last updated?

The most recent TECH report was published on November 14, 2026.

What do analysts expect for TECH?

As of November 1, 2026, the analyst consensus on TECH is Hold (0 Strong Buy, 0 Buy, 12 Hold, 1 Sell, 0 Strong Sell). As of November 20, 2026, the analyst price target is $71.67 mean (range $65.00 to $73.00).

Is this TECH research investment advice?

No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.

Keep exploring